TOP TIERMARKET NEWSWIRE

News & sentiment

GSK PLC ADR ADR (GSK) — News & AI sentiment

GSK PLC ADR ADR (GSK) news roundup. 19 stories in the past week, 37 over 30 days. Average 30-day sentiment is 56.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

19

avg sentiment 56.5/100

30d stories

37

avg sentiment 56.7/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

Latest stories on GSK

GSK plc (GSK) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

1d ago

GSK: Healthy Results, But Limited Stock Upside (Rating Downgrade)

Seeking Alpha54 · neutralearnings

2d ago

GSK plc 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

2d ago

GSK launches $2.5 billion savings drive to invest in drug pipeline

Investing.com Markets56 · neutralgeneral

2d ago

GSK declares $0.4518/ADS or 17p/share dividend

Seeking Alpha50 · neutralgeneral

2d ago

GSK Q2 2026 earnings beat: £1.9B cost-savings plan launched - qz.com

Quartz63 · neutralearnings

2d ago

GSK Q2 2026 earnings beat: £1.9B cost-savings plan launched

Yahoo Top67 · bullishearnings

2d ago

GSK is slashing costs by $2.5 billion to fast-track its drug pipeline

Quartz63 · neutralgeneral

2d ago

GSK announces $2.5B cost savings program to fund R&D

Seeking Alpha63 · neutralgeneral

2d ago

GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline

WSJ Business56 · neutralgeneral

2d ago

Why is GSK stock surging today?

Investing.com Markets50 · neutralgeneral

2d ago

GSK Non-GAAP EPS of £0.51 beats by £0.02, revenue of £8.41B beats by £4.05B; reaffirms FY2026 outlook

Seeking Alpha68 · bullishearnings

2d ago

GSK launches $2.5 billion savings drive to boost drug pipeline

Yahoo Finance56 · neutralgeneral

2d ago

GSK beats second-quarter profit estimates, launches $2.52 billion cost savings drive

Reuters63 · neutralearnings

2d ago

GSK Plans Annual Savings of £1.9 Billion to Enable R&D Spend

Bloomberg56 · neutralgeneral

2d ago

GSK Earnings Preview: EPS to take a plunge; CEO's comments, guidance in focus

Seeking Alpha32 · bearishearnings

3d ago

GSK Discloses July 22 Executive ADS Acquisition by U.S. President

TipRanks50 · neutralgeneral

6d ago

GSK Adds 70,759 Shares to LSE Listing Under 2022 Share Save Plan

TipRanks50 · neutralgeneral

6d ago

GSK’s Jideytro Gains Early FDA Approval for ROS1-Positive Lung Cancer—44% Response Rate Signals Major Step in Targeted Therapy July 23, 2026

MarketChameleon76 · bullishproduct/pr

7d ago

GSK enters lung cancer drug market with early FDA nod for Jideytro

Reuters63 · neutralproduct/pr

Jul 22

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

PR Newswire73 · bullishproduct/pr

Jul 22

GSK enters lung cancer market with FDA nod for Jideytro

Seeking Alpha67 · bullishproduct/pr

Jul 22

GSK’s New Malaria Candidate Advances With Key Drug-Interaction Study

TipRanks63 · neutralproduct/pr

Jul 21

GSK: Buy The Discount Before The Catalysts Close It

Seeking Alpha63 · neutralanalyst

Jul 21

GSK Updates Key Pediatric Flu Study, Signaling Quiet Upside for Its Antiviral Portfolio

TipRanks58 · neutralproduct/pr

Jul 20

Open GSK in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →